Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib

British Journal of Cancer, Published online: 27 January 2024; doi:10.1038/s41416-024-02580-3Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib

https://www.nature.com/articles/s41416-024-02580-3

Source: British Journal of Cancer - January 27, 2024 Category: Cancer & Oncology Authors: Thomas Gaillard Jeanne Piketty Jean-Guillaume Feron Noemie Girard Lea Pauly Elodie Gauroy Lauren Darrigues Beatriz Grandal Jean-Yves Pierga Anne-Sophie Hamy-Petit Fabien Reyal Enora Laas Source Type: research